Insys Therapeutics, Inc.·4

Apr 23, 7:14 PM ET

Vanhove Geertrui 4

4 · Insys Therapeutics, Inc. · Filed Apr 23, 2019

Insider Transaction Report

Form 4
Period: 2018-04-02
Transactions
  • Award

    Common Stock

    2019-03-04+8,08314,083 total
  • Award

    Employee Stock Option (right to buy)

    2018-04-02+24,00024,000 total
    Exercise: $5.96Exp: 2028-04-01Common Stock (24,000 underlying)
  • Award

    Common Stock

    2018-04-02+6,0006,000 total
  • Award

    Employee Stock Option (right to buy)

    2019-03-04+20,93520,935 total
    Exercise: $6.36Exp: 2029-03-03Common Stock (20,935 underlying)
Footnotes (2)
  • [F1]The option vests in 36 equal monthly installments and will be fully vested and exercisable on April 2, 2021.
  • [F2]The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION